Literature DB >> 6311959

Inhibition of retrovirus RNA-dependent DNA polymerase by novobiocin and nalidixic acid.

Y Sumiyoshi, T Nishikawa, T Watanabe, K Kano.   

Abstract

Inhibitors of bacterial DNA gyrase and eukaryotic DNA topoisomerase (novobiocin and nalidixic acid) were investigated with respect to their effect on the activity of RNA-dependent DNA polymerases from murine and avian retroviruses. Purified RNA-dependent DNA polymerase from AKR virus was inhibited more than 90% by 0.3 mg/ml and almost completely by 1 mg/ml of the drugs when poly(A) X oligo(dT)12-18 was used as a template-primer. In contrast to the enzyme from AKR virus, purified enzyme from avian myeloblastosis virus was less sensitive, i.e. nearly 50% activity remained even in the presence of 1 mg/ml of the drugs with the same template-primer. RNA-dependent DNA polymerase activity in AKR virus particles was inhibited, but was resistant to low concentrations of the drugs. The inhibition was not due to specific interaction between drugs and the template-primer or labelled precursor, since RNA-dependent DNA polymerase was inhibited by the drugs with activated calf thymus DNA or poly(C) X oligo(dG)12-18 as the template. Endogenous DNA synthesis by AKR virus particles was inhibited by novobiocin to the same extent.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6311959     DOI: 10.1099/0022-1317-64-10-2329

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  3 in total

1.  Sedimentation of an RNA polymerase complex from vaccinia virus that specifically initiates and terminates transcription.

Authors:  S S Broyles; B Moss
Journal:  Mol Cell Biol       Date:  1987-01       Impact factor: 4.272

2.  Theiler's murine encephalomyelitis virus infection induces a redistribution of heat shock proteins 70 and 90 in BHK-21 cells, and is inhibited by novobiocin and geldanamycin.

Authors:  Lorraine Z Mutsvunguma; Boitumelo Moetlhoa; Adrienne L Edkins; Garry A Luke; Gregory L Blatch; Caroline Knox
Journal:  Cell Stress Chaperones       Date:  2011-03-29       Impact factor: 3.667

3.  Use of fluoroquinolones in patients with chronic hepatitis C virus-induced liver failure.

Authors:  H Kojima; K D E Kaita; K Hawkins; J Uhanova; G Y Minuk
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.